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Chapter 12
SUMMARY AND GENERAL DISCUSSION
12.1. Summary
Asthma is characterised by episodic, variable airflow-obstruction and increased responsiveness
of the airways to a variety of stimuli. Moreover, asthma is not a single disease ntity but
should be considered as a group of disorders which have in common the clinical manifestations
of variable airways obstruction and hypenesponsiveness. The list of agents that can provoke
bronchoconstriction, sometimes called "triggers" of asthma, is long and includes not only the
antigens but also a wide variety of materials that appear unlikely to act through an
immunological mechanism. These agents are often called "non-specific" stimuli and include
many agents and/or events. The ability of these stimuli to provoke bronchoconstriction is a
function of the responsiveness of the airway.
With our increased knowledge of the disease, during the past decades, more complex models of
asthma have been constructed in which two areas currently seem to be of prime importance:
bronchial hyperresponsiveness (BFIR) and inflammation of the airways.
However. it is. perhaps, too simple to expect hat there would be a straightforward association
between inflammation and BHR, as both of these terms encompass a range of heterogeneous
conditions. If inflammation in general does not cause BHR, it is of interest o know the type
of inflammation that may do so, or under what particulal circumstances.
BHR increases upon natural exposure to airborne allergens or occupational sthma inducers.
Conversely, removal from environmental exposure often results in a decreased BHR. An
enhanced BHR following the late asthmatic response (LAR) induced by allergen provocation in
sensitized human subjects has been observed. Interest is being shown in changes in BHR
which precede the late asthmatic response. Observations suggest that the tissue damage, which
is supposed to cause the increase in BHR, may occur before the LAR is clinically evident.
It is still uncertain what distinguishcs late asthmatic responders from nonlate responders. Such
a dtsttnction is ol importancr henuv.t.h: C:gree 0f l,+c L,1R clirclaics with the seventy o(
asthma symptoms. The severity of the pre-existing BHR and the allergen-induced increase in
BHR may predict whether patients develop a LAR. This will support he hypothesis of a
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positive feedback loop, in which patients who are more hyperresponsive develop a LAR after
allergen exposure, which in turn induces an increase in BHR.
Histological studies almost invariably show that asthma is accompanied by inflammatory
changes in the walls of the airways.
It is suggested that the allergen-induced increase in BHR and the development of an early
asthmatic reaction (EAR) and LAR may both depend on inflammatory changes. As a
consequence, such mechanisms may explain the clinical usefulness of anti-inflammatory drugs
against EARs, LARs and BHR.
Therefore the model of allergen provocation may provide clinical information, but also
information about the dynamics of allergen induced changes in the bronchial wall. Trying to
understand this model, it may give some answers as to why and how inflammation occurs in
allergic asthmatics and may be related to the clinical picture of asthma.
This thesis deals with the effects of allergen provocation on bronchial hyperresponsivencss.
Clinical and immunohistological aspects have been studied and will be summarised. To allow
for critical evaluation of the results an overview is presented of the anatomy. morphology, and
histopathology of the bronchial tree and the different aspects of bronchial hyperresponsiveness.
Chapter I deals with the anatomy and morphology of the br<lnchial tree.
Chapter 2 describes the pathology of the airways in asthmatics and several aspects of
bronchial biopsies and bronchoalveolar lavage. Chapter 3 gives an overview of bronchial
hlperresponsiveness and deals with diagnosis, clinical aspects, agcnts, allergen-induced churgcs
in bronchial hypenesponsiveness and mechanisms. Finally, in Chapter 4 the aims of thc
studies are delineated.
Chapter 5 describes the effect of allergen provocation on bronchial hypenesponsiveness,
measured with methacholine and adenosine 5'-monophosphate (AMP). The allergen induced
changes irr BHR are studied at 3 h and 24 h after allergen challenge, when the FEV, is returned
to prechallenge values. The magnitude of the decrease in PCro methacholine at 3 h correlates
with the sevcrity of the late asthmatic reaction. A significiurt decrease is observed in the PCro
methacholine and PCr,, AMP at 3 h. In contrast to methacholine, no significant decrease can
be demonstrated with AMP for the PCrn ^ t 24 h.
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In Chapter 6 the results of Chapter 5 are further analysed to see how Nedocromil sodium, an
anti-inflammatory compound, interacts with the early asthmatic reaction (EAR), late asthmatic
reaction (LAR) and allergen-induced increase in BHR, measured with methacholine.
Nedocromil sodium inhibits the increase in BHR at 3 h and 24 h, diminishes the severity of
the EAR and inhibits lhe LAR.
Chapter 7 further analyses the effect of Nedocromil sodium, however instead of looking after
its effects on BHR, measured with methacholine, now AMP is used to measure the allergen-
induced increase in BHR. Nedocromil sodium given before allergen challenge prevents the
increased responsiveness to AMP at 3 h, but causes a decrease in PCro AMP at 24 h.
Desensitisation of the adenosine receptor during the LAR, that is prevented by Nedocromil
sodium, may explain the increased responsiveness at 24 h.
Furthermore this chapter briefly deals with the allergen-induced increase in BHR, measured at a
time point when allergen-induced bronchoconstriction is sti l l  present and the supposed
beneficial eff'ect of the cysteinyl-leukotriene receptor antagonist lcl 2M.219 on allergen-
induced increare in BHR. The effect of the studied compound may be a consequence of the
reduction of airway calibre and not of allergen-induced increase in BHR.
Chapter 8 deals with potential cellular differences in the lung on a bronchial and broncho-
alveolar level between single early asthmatic responders and dual asthmatic responders. Dual
responders have a significant higher number of eosinophils and activated (EG2) eosinophils in
their bronchial lavage compared to the single early responders. No differences are observed in
the number of CD4+. CD8+ urd HLA-DR positive cells. The observed differences are mainly
found in the bronchial lavage and not in the broncho-alveolar lavage.
Looking after the clinical effects of allergen challenge on BHR in chapters 5,6, and 7, in
Chapter 9 the effects of allergen challenge on inllammatory cells in the airways are studied
before, 3 h and 24 h after house dust mite challenge, performing bronchial and broncho-
alveolar lavage. and using differential cell counting and immunohistochemistry. Clear
differences are seen between bronchial and bronchoalveolar lavage. Activated @G2) eosinophils
are significantly increased at 3 h and 24 h after challenge both in single early and dual
asthmatic responders, compared with prechallenge values. The number of activated (EG2)
eosinophils are significantly higher at 3 h and at 24 h in patients who clinically develop a late
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asthmatic reaction. No significant changes are observed in the number of CD3*, CD4*, and
CD8* cells 3 and 24 h after the challenge.
Chapter 10 describes the effects of allergen challenge on eosinophilic activity at 3 h and 24
h after challenge, measured in the bronchial submucosa, bronchial lavage and bronchoalveolar
lavage in dual asthmatic responders. The numbers of activated (EG2) eosinophils are
significantly increased both at 3 h and 24 h in the submucosa nd bronchial lavage. A
significant negative correlation is found between the number of activated (EG2) eosinophils in
the submucosa nd in the BL 24 h after the allergen challenge. At 24 h the amount of
eosinophilic cationic protein (ECP) is increased in the bronchial lavage. A significant
correlation is observed between the amount of ECP at 3 h and the log PDro house dust mite.
In Chapter 11 the changes in the number of activated (EG2) eosinophils and T-lymphocytes
in the bronchial submucosa re described 3 h and 24 h after allergen challenge. Furthermore the
interaction between these cells is discussed. After challenge, a significant increase in the
number of CD8* T-lymphocytes and activated (EG2) eosinophils i  observed at 3 h md 24 h
after challenge in the bronchial submucosa. Strong positive correlations are found between
activated (EG2) eosinophils before the challenge and CD3* T-lymphocytes at24 h after the
challenge, and between activated (EG2) eosinophils before the challenge and CD4* T-lympho-
cytes at 24 h after challenge. The change in CD8* T-lymphocytes between before and 24 h
after the challenge conelates inversely with the severity of the late asthmatic reaction
12.2. Conclusions
Allergen-induced increase in bronchial hyperresponsiveness is present between the early
and late asthmatic reaction, as measured with a direct and an indirect stimulus. The pre-
existing BHR and increased BHR at 3 h is related to the development of the late
asthmatic reaction after allergen challenge.
The differences found in the increase in BHR between the direct stimulus methacholine
and the indirect stimulus AMP support the view that direct and indirect mechanisms are





































The beneficial effect of Nedocromil sodium on the allergen-induced changes in BHR
indicates that the allergen-induced changes in BHR are mainly the result of allergen-
induced inflammatory changes in the bronchial wall.
The number of activated (EG2) eosinophils in the bronchial lavage discriminates
between single early and dual asthmatic responders.
Activated (EG2) eosinophils in the bronchial lavage are associated with the allergen-
induced increase in BHR at 3 and 24 hours and the tendency to develop a late asthmatic
response.
Allergen challenge causes an increase in activated @G2) eosinophils before and after the
late asthmatic reaction. Activated (EG2) eosinophils show a shift from the submucosa
to the epithelial lining, as concluded from the biopsies and lavages.
Activated (EG2) eosinophils are not only effector cells, but are also pro-inflammatory
cells playing an active role in the recruitment of other inflammatory cells in relation to
allergen challenge. CD8* T-lymphocytes play a role in diminishing the late asthmatic
reaction after allergen challenge in allergic asthmatics.
12.3.  General  d iscussion
As described, the aim of this study was to investigate the nature and development of the
allergen-induced inflammatory responses in allergic asthmatic patients between the early and
late and after the late asthmatic reaction. Moreover, we fied to define a causal relation between
these inf'lammatory events and the allergen-induced changes in bronchial hyperresponsiveness
and its relation to the late asthmatic response.
Having summarised the main results of the studies it is necessary to give these results a more
general perspective by discussing their possible contribution to the understanding of the
mechanisms of allergen-induced changes in bronchial hypenesponsiveness.
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Bronchoalveolar lavage has increased our knowledge about the inflammatory events taking
place in the lungs of asthmatics. Indeed in addition to clinical observations it has provided
clues for considering inflammation as the basis of the disease. It was hoped that any cellular
pattern observed would mirror the same processes occurring within the lung parenchyma.
However, this proved not to be the case1,2. Bronchoalveolar lavage provides information about
cells present at the epithelial surface of the lung. The rapid exchange of instilled fluid with
extra cellular fluid in the lung complicates the measurements of soluble mediators of
inflammation recovered by lavage.
Attention is focused now on biopsy findings in asthma and when appropriate, supplemented
with lavage. Before discussing our results it is important to make some remarks concerning
the procedure it self. It is suggested that fiberoptic bronchoscopy should only be undertaken in
subjects with mild asthma. whose FEV, is >70Vo predicted and PCro histamine or
methacholine is >0.1 mg/ml when measured by the standard procedures of Cockcroft3 .
Because of this we have had long discussions whether it is ethically allowed and safe from a
medical point of view using fiberoptic bronchoscopy, to perform lavage and taking biopsies on
three separate occasions, before and after allergen challenge, knowing that the patient is very
hyperreactive and may have discomfort.
In all the procedures we have not experienced any short- or long-term problems, but it should
be stressed that the procedure must be explained to the patient, and must be carried out by
experienced staff in a specialised unit designed for studies of this sort and not pafi of a routine
clinical service.
Although it is suggested that the division of lavage specimens into wash and BAL does not add
further information with regard to the distinction between asthmatics and nonasthmaticsa, it
provides clear information in distinguishing be{ween patients with only an early asthmatic
reaction and dual responders. In addition, comparing bronchial lavage findings with submucosal
findings, extra information is obtained about the dynamics of cell movement from the
submucosa to the epithelial l ining.
What does the lavage information add to our knowledge about single and dual responders'/ At
first, single responders show signs of inflammation in the lavage, but less pronounced
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Second. changes in the number of inflammatory cells do occur after allergen provocation, again
less pronounced compared to dual responders. These findings indicate that the difference
between single and dual responders is not a qualitative difference but a quantitative one. Down-
regulation may take place in patients with asthma, but is probably insufficient.
We have the impression from the biopsies taken that patients with only a single early reaction
show a larger increase in the number of CDS* T-lymphocytes 3 h after challenge than the dual
responders. This impression is supported by the finding of a negative correlation between the
severity of the late asthmatic response and the increase in the number of CD8* cells in the dual
responders. It may thus suggest that down-regulation in single responders is better organised
than in dual responden.
Our results partly endorse the opinion that lavage findings do not exactly mirror events taking
place in the submucosa. However, this seems to be restricted to T-lymphocytes and not to
eosinophils.
The evolving recognition of the capacity of eosinophils to engage in other types of cellular
responses suggests that eosinophils can collaborate with lymphocytes and other immunologic
and mesenchymal cells in various ways that are pertinent to health and disease. Eosinophils
can express cell-surface proteins that may enable them to interact with lymphocytes. The
ability of eosinophils, after in vitro induction of HLA-DR, to function as antigen presenting
cells indicates that they could interact with CD4 lymphocytes to elicit antigen-specific
lymphocyte responsess.
Our results concerning the biopsy findings before and after allergen challenge in the dual
responders, with respect to the correlations found between the number of activated (EG2)
eosinophils before the challenge and the number of CD3* and CD4* T-lymphocytes after the
challenge indeed suggest that this occurs in vivo in asthmatic patients.
At the time of writing, it is probably premature to define the position of eosinophils in
orchestrating inflammatory responses to inhaled allergen in asthma. Although in view of their
capacities pertinent to the type of inflammation seen in asthma. this component of the
mucosal immune system may be the necessary link between the induction of an asthmatic
response and its subsequent propagation.
In the 1970s GOkemeyer and Hargreave & co-workers established that the changes in bronchial
hyperresponiveness een after late responses occur and could even persist for weeks6'7. One
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single bronchial challenge could produce an increase in bronchial hyperresponsiveness 2 weeks
out and against an apparently normal FEV,.
The question is: Is that a model for the way in which bronchial hyperresponsiveness is
developed in the natural world? An other question is, whether the experimental challenge model
provides insight into chronicity of asthma and whether the late response does duplicate chronic
disease. To date, these questions are not yet solved. However, it seems of great importance to
understand these phenomena, since the degree of hypenesponsiveness has been shown to be
related to the severity of the disease. It has been suggested that the degree of
hyperresponsiveness is correlated to the progression in lung function deterioration in chronic
airflow obstructions-l l.
Bronchial hypenesponsiveness and allergen-induced changes in bronchial hyperresponsiveness
in asthma can be measured using direct and indirect stimuli.
In addition, by using direct and indirect stimuli substantial extra information can be obtained,
not only by discriminating between different clinical entit ies, but also in respect to
pathological processes involved. We demonstrated that patients with only an early asthmatic
reaction may develop an allergen-induced increase in bronchial hyperresponsiveness as well,
suggesting that allergen-induced increase in bronchial hyperresponsiveness as such does not
discriminate between patients with only an early asthmatic reaction and dual responders.
Our studies also indicate, that bronchial hypenesponsiveness does not increase per sd after
allergen challenge, but that it depends on the stimulus used in the procedure to measure
bronchial hyperresponsiveness.
The results of this study ask for further research, especially focused on the dynamics of the
inflammatory process. It seems clear now that the number and type of inflammatory cells in
the submucosa and epithelial lining do play an important and possibly crucial role in allergen-
induced changes in bronchial hypenesponsiveness. However, we still do not know how these
cells interact, what factors or cells are responsible for the attraction of these cells to the
submucosa and subsequent epithelial lining.
With the acquired and increased knowledge it is now necessary to solve these questions in order
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